Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a publicly traded Healthcare sector company. As of November 19, 2026, AMRX trades at $21.63 with a market cap of $7.36B and a P/E ratio of 41.12. AMRX moved +3.67% today. Year to date, AMRX is +72.22%; over the trailing twelve months it is +89.19%. Its 52-week range spans $6.69 to $22.12. Analyst consensus is strong buy with an average price target of $24.83. Rallies surfaces AMRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. AMRX moved +3.67% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $21.63 |
| Market Cap | $7.36B |
| P/E Ratio | 41.12 |
| EPS | $0.50 |
| Dividend Yield | 0.00% |
| 52-Week High | $22.12 |
| 52-Week Low | $6.69 |
| Volume | 1.53M |
| Avg Volume | 0 |
| Revenue (TTM) | $3.12B |
| Net Income | $215.32M |
| Gross Margin | 39.32% |
6 analysts cover AMRX: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.83.